Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-10-30 | New | $134,188,389 | $134,188,389 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Quehuong (Kathy) Dong, Pharm.D. | Director, Executive |
| Matthew Fust | Director |
| Thomas Geninatti, Ph.D. | Director |
| Carl Gordon, Ph.D. | Director |
| Beth Seidenberg, M.D. | Director |
| Nancy Stagliano, Ph.D. | Director |